This HTML5 document contains 63 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n17https://global.dbpedia.org/id/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n16http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n7http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:5-MBPB
rdf:type
dbo:ChemicalSubstance wikidata:Q8386 owl:Thing dbo:Drug n16:ChemicalObject
rdfs:label
5-MBPB
rdfs:comment
5-MBPB (also known as 5-MPBP and 5-MABB) is an amphetamine derivative which is structurally related to MDMA and has been sold as a designer drug. It can be described as the benzofuran-5-yl analogue of MBDB or the butanamine homologue of 5-MAPB, and is also a structural isomer of 5-EAPB and 6-EAPB. Anecdotal reports suggest this compound has been sold as a designer drug in various European countries since early 2015, but the first definitive identification was made in December 2015 by a forensic laboratory in Slovenia.
foaf:depiction
n7:5-MBPB_structure.png
dcterms:subject
dbc:5-Benzofuranethanamines dbc:Substituted_amphetamines dbc:Entactogens_and_empathogens dbc:Designer_drugs
dbo:wikiPageID
51999594
dbo:wikiPageRevisionID
1075459344
dbo:wikiPageWikiLink
dbr:5-EAPB dbr:Benzofuran dbc:5-Benzofuranethanamines dbr:Designer_drug dbr:Slovenia dbr:Substituted_amphetamine dbr:6-EAPB dbr:Structural_isomer dbr:Structural_analog dbr:5-APB dbr:5-HT2C dbr:Homology_(chemistry) dbc:Entactogens_and_empathogens dbc:Substituted_amphetamines dbr:MBDB dbr:5-MAPB dbr:MDMA dbc:Designer_drugs
owl:sameAs
wikidata:Q27294523 yago-res:5-MBPB n17:2YxNB
dbp:wikiPageUsesTemplate
dbt:Cascite dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Entactogens
dbo:thumbnail
n7:5-MBPB_structure.png?width=300
dbp:atcPrefix
none
dbp:c
13
dbp:chemspiderid
52085237
dbp:h
17
dbp:iupacName
1
dbp:legalDe
NpSG
dbp:legalUk
Class B
dbp:molecularWeight
203.28
dbp:n
1
dbp:o
1
dbp:pubchem
139033209
dbp:smiles
CCCNC
dbp:stdinchi
1
dbp:stdinchikey
CTEZPBCLIKEASW-UHFFFAOYSA-N
dbp:unii
YHB7YWS4WJ
dbo:abstract
5-MBPB (also known as 5-MPBP and 5-MABB) is an amphetamine derivative which is structurally related to MDMA and has been sold as a designer drug. It can be described as the benzofuran-5-yl analogue of MBDB or the butanamine homologue of 5-MAPB, and is also a structural isomer of 5-EAPB and 6-EAPB. Anecdotal reports suggest this compound has been sold as a designer drug in various European countries since early 2015, but the first definitive identification was made in December 2015 by a forensic laboratory in Slovenia. 5-MBPB is similar in structure to compounds such as 5-APB which are claimed to be agonists of the 5-HT2C receptor.
dbp:legalCa
Schedule I
prov:wasDerivedFrom
wikipedia-en:5-MBPB?oldid=1075459344&ns=0
dbo:wikiPageLength
2384
dbo:fdaUniiCode
YHB7YWS4WJ
dbo:pubchem
139033209
foaf:isPrimaryTopicOf
wikipedia-en:5-MBPB